Talaporfin sodium. LS 11, ME 2906, mono-L-aspartyl chlorine e6, NP e6, NPE 6, taporfin sodium.
D000818:Animals; D018281:Cholangiocarcinoma / Q000188:drug therapy*; D017321:Clinical Trials, Phase I as Topic; D015507:Drugs, Investigational; D006801:Humans; D007275:Injections, Intravenous; D009369:Neoplasms / Q000178:diet therapy*; D017319:Photosensitizing Agents / Q000494:pharmacology*; D011166:Porphyrins / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
D015507:Drugs, Investigational; D017319:Photosensitizing Agents; D011166:Porphyrins; C053434:Talaporfin